Pacira | PCRX - Dochód Netto





Dochód Netto Zmiana Data
Astellas Pharma JPY 141.83B 98.31B 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Cara Therapeutics USD -6.8M 1.28M 2026-03
Coherus Biosciences USD -37.64M 2.11M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
J&J USD 5.53B 299M 2026-06
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Novo Nordisk DKK 20.99B 5.9B 2026-06
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 4.65M 1.74M 2026-06
Perrigo USD 74.5M 473.1M 2026-06
Pfizer USD -248M 2.94B 2026-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
Teva Pharmaceutical Industries USD -576M 945M 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zoetis USD 691M 90M 2026-06